Foldover sensors and methods for making and using them
    2.
    发明授权
    Foldover sensors and methods for making and using them 有权
    折叠传感器和制造和使用它们的方法

    公开(公告)号:US09493807B2

    公开(公告)日:2016-11-15

    申请号:US13779271

    申请日:2013-02-27

    摘要: The invention disclosed herein includes sensors having three dimensional configurations that allow expansive “360°” sensing (i.e. sensing analyte from multiple directions) in the environments in which such sensors are disposed. Embodiments of the invention provide analyte sensors having foldable substrates adapted to produce optimized configurations of electrode elements as well as methods for making and using such sensors. Typical embodiments of the invention include glucose sensors used in the management of diabetes.

    摘要翻译: 本文公开的本发明包括具有三维结构的传感器,其在这些传感器被布置的环境中允许宽广的“360°”感测(即感测来自多个方向的分析物)。 本发明的实施例提供了分析物传感器,其具有适于产生电极元件的优化配置的可折叠基底以及用于制造和使用这种传感器的方法。 本发明的典型实施方案包括用于治疗糖尿病的葡萄糖传感器。

    FOLDOVER SENSORS AND METHODS FOR MAKING AND USING THEM
    3.
    发明申请
    FOLDOVER SENSORS AND METHODS FOR MAKING AND USING THEM 有权
    FOLDOVER传感器及其制造和使用方法

    公开(公告)号:US20130313130A1

    公开(公告)日:2013-11-28

    申请号:US13779271

    申请日:2013-02-27

    IPC分类号: C12Q1/00 G01N27/327

    摘要: The invention disclosed herein includes sensors having three dimensional configurations that allow expansive “360°” sensing (i.e. sensing analyte from multiple directions) in the environments in which such sensors are disposed. Embodiments of the invention provide analyte sensors having foldable substrates adapted to produce optimized configurations of electrode elements as well as methods for making and using such sensors. Typical embodiments of the invention include glucose sensors used in the management of diabetes.

    摘要翻译: 本文公开的本发明包括具有三维结构的传感器,其在这些传感器被布置的环境中允许宽广的“360°”感测(即感测来自多个方向的分析物)。 本发明的实施例提供了分析物传感器,其具有适于产生电极元件的优化配置的可折叠基底以及用于制造和使用这种传感器的方法。 本发明的典型实施方案包括用于治疗糖尿病的葡萄糖传感器。

    ORTHOGONALLY REDUNDANT SENSOR SYSTEMS AND METHODS

    公开(公告)号:US20220087578A1

    公开(公告)日:2022-03-24

    申请号:US17542655

    申请日:2021-12-06

    摘要: A continuous glucose monitoring system may include a hand-held monitor, a transmitter, an insulin pump, and an orthogonally redundant glucose sensor, which may comprise an optical glucose sensor and a non-optical glucose sensor. The former may be a fiber optical sensor, including a competitive glucose binding affinity assay with a glucose analog and a fluorophore-labeled glucose receptor, which is interrogated by an optical interrogating system, e.g., a stacked planar integrated optical system. The non-optical sensor may be an electrochemical sensor having a plurality of electrodes distributed along the length thereof. Proximal portions of the optical and electrochemical sensors may be housed inside the transmitter and operationally coupled with instrumentation for, e.g., receiving signals from the sensors, converting to respective glucose values, and communicating the glucose values. The sensors' distal portions may be inserted into a user's body via a single delivery needle and may be co-located inside the user's body.

    Orthogonally redundant sensor systems and methods

    公开(公告)号:US11229384B2

    公开(公告)日:2022-01-25

    申请号:US16203951

    申请日:2018-11-29

    摘要: A continuous glucose monitoring system may include a hand-held monitor, a transmitter, an insulin pump, and an orthogonally redundant glucose sensor, which may comprise an optical glucose sensor and a non-optical glucose sensor. The former may be a fiber optical sensor, including a competitive glucose binding affinity assay with a glucose analog and a fluorophore-labeled glucose receptor, which is interrogated by an optical interrogating system, e.g., a stacked planar integrated optical system. The non-optical sensor may be an electrochemical sensor having a plurality of electrodes distributed along the length thereof. Proximal portions of the optical and electrochemical sensors may be housed inside the transmitter and operationally coupled with instrumentation for, e.g., receiving signals from the sensors, converting to respective glucose values, and communicating the glucose values. The sensors' distal portions may be inserted into a user's body via a single delivery needle and may be co-located inside the user's body.